Reappraisal of Failures in Downstaging Treatment of Hepatocellular Carcinoma Prior to Liver Transplant-Preliminary Report on the Impact of Underestimations of Tumor Numbers and Tumor Sizes as Measured From Imaging Before Transplant.
Sign Up to like & getrecommendations! Published in 2019 at "Transplantation proceedings"
DOI: 10.1016/j.transproceed.2019.03.020
Abstract: Downstaging treatment of hepatocellular carcinoma (HCC) prior to liver transplant (LT) is an accepted strategy to meet the Milan criteria. However, after transplant surgery, a reality is noted that the number or/and the size of… read more here.
Keywords: hepatocellular carcinoma; downstaging treatment; treatment hepatocellular; number ... See more keywords
Discovery of Novel 7-Azaindole Derivatives as Selective Covalent Fibroblast Growth Factor Receptor 4 Inhibitors for the Treatment of Hepatocellular Carcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.2c00255
Abstract: Fibroblast growth factor receptor 4 (FGFR4) has been identified as a potential target for the treatment of hepatocellular carcinoma (HCC) with aberrant FGFR4 signaling because of its important role in HCC progression and development. Several… read more here.
Keywords: fgfr4; treatment hepatocellular; factor receptor; growth factor ... See more keywords
Tivantinib for the treatment of hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1316376
Abstract: ABSTRACT Introduction: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide with a poor prognosis due to late diagnosis in the majority of cases. Physicians are frequently confronted with patients who… read more here.
Keywords: hepatocellular carcinoma; tivantinib treatment; treatment hepatocellular; treatment ... See more keywords
Response to Letter: Hepatocellular Carcinoma: The Gap Between Eastern and Western Clinical Practice.
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Surgery"
DOI: 10.1097/sla.0000000000001961
Abstract: 4. Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res. 2009;39:107–116. 5. Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation. N… read more here.
Keywords: hepatocellular carcinoma; carcinoma; treatment hepatocellular; kokudo hasegawa ... See more keywords
Sorafenib and Lenvatinib as first‐line treatment of hepatocellular carcinoma: A still controversial comparison
Sign Up to like & getrecommendations! Published in 2021 at "Liver International"
DOI: 10.1111/liv.14853
Abstract: I read with interest the study by CasadeiGardini et al who compared the effects of sorafenib and lenvatinib as firstline treatment of hepatocellular carcinoma (HCC) in the reallife setting, through inverse probability of treatment weighting… read more here.
Keywords: sorafenib lenvatinib; treatment hepatocellular; treatment; study ... See more keywords
The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Surgical Oncology"
DOI: 10.1186/s12957-021-02451-8
Abstract: Background The timely and effective treatments are vital to the prognosis of patients with hepatocellular carcinoma, and the role of Apatinib combined with TACE in the treatment of hepatocellular carcinoma remains unclear. Therefore, we aimed… read more here.
Keywords: treatment hepatocellular; hepatocellular carcinoma; tace; apatinib combined ... See more keywords
Dose age affect the efficacy of molecular targeted agents in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.22061
Abstract: Currently, whether the impact of age on efficacy of molecular targeted agents (MTAs) in the treatment of hepatocellular carcinoma (HCC) patients remains undetermined. We searched databases and abstracts presented at ASCO meeting to identify relevant… read more here.
Keywords: efficacy molecular; age; treatment hepatocellular; treatment ... See more keywords
Bridging therapy effectiveness in the treatment of hepatocellular carcinoma prior to orthotopic liver transplantation.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of gastrointestinal oncology"
DOI: 10.21037/jgo.2017.08.11
Abstract: Background Orthotopic liver transplantation (OLT) is the most effective treatment for hepatocellular carcinoma (HCC) in patients with underlying cirrhosis and portal hypertension. Availability of OLT is limited by donor-organ shortages, which increase patient waiting time… read more here.
Keywords: hepatocellular carcinoma; treatment hepatocellular; treatment; orthotopic liver ... See more keywords
The Potential Use of Anticancer Peptides (ACPs) in the Treatment of Hepatocellular Carcinoma.
Sign Up to like & getrecommendations! Published in 2019 at "Current cancer drug targets"
DOI: 10.2174/1568009619666191111141032
Abstract: Peptides have acquired increasing interest as promising therapeutics, particularly as anti-cancer alternatives during the recent years. They have been reported to demonstrate incredible anti-cancer potentials due to its low manufacturing cost, ease of synthesis and… read more here.
Keywords: hepatocellular carcinoma; treatment hepatocellular; carcinoma; anticancer peptides ... See more keywords
Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and Challenges
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.690565
Abstract: Immunotherapy has become an indispensable part of the comprehensive treatment of hepatocellular carcinoma (HCC). Immunotherapy has proven effective in patients with early HCC, advanced HCC, or HCC recurrence after liver transplantation. Clinically, the most commonly… read more here.
Keywords: hepatocellular carcinoma; hcc; treatment hepatocellular; treatment ... See more keywords
Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineering
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1150151
Abstract: Hepatocellular carcinoma (HCC) is a major global health burden, causing approximately 8.3 million deaths each year, and it is the third leading cause of cancer-related death worldwide, with a relative 5-year survival rate of around… read more here.
Keywords: hepatocellular carcinoma; treatment hepatocellular; therapy; medicine ... See more keywords